These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 30949842)

  • 1. Conversion surgery for initially unresectable pancreatic cancer: current status and unresolved issues.
    Yoshitomi H; Takano S; Furukawa K; Takayashiki T; Kuboki S; Ohtsuka M
    Surg Today; 2019 Nov; 49(11):894-906. PubMed ID: 30949842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Single-Institution Experience of Induction 5-Fluorouracil, Leucovorin, Irinotecan, and Oxaliplatin Followed by Surgery Versus Consolidative Radiation for Borderline and Locally Advanced Unresectable Pancreatic Cancer.
    Cecchini M; Miccio JA; Pahade J; Lacy J; Salem RR; Johnson SB; Blakaj A; Stein S; Kortmansky JS; Johung KL
    Pancreas; 2020 Aug; 49(7):904-911. PubMed ID: 32658074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of chemotherapy and significance of conversion surgery after chemotherapy in unresectable pancreatic cancer.
    Furuse J; Shibahara J; Sugiyama M
    J Hepatobiliary Pancreat Sci; 2018 May; 25(5):261-268. PubMed ID: 29651809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resectability After First-Line FOLFIRINOX in Initially Unresectable Locally Advanced Pancreatic Cancer: A Single-Center Experience.
    Nitsche U; Wenzel P; Siveke JT; Braren R; Holzapfel K; Schlitter AM; Stöß C; Kong B; Esposito I; Erkan M; Michalski CW; Friess H; Kleeff J
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1212-20. PubMed ID: 26350368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. R0 resection following chemo (radio)therapy improves survival of primary inoperable pancreatic cancer patients. Interim results of the German randomized CONKO-007± trial.
    Fietkau R; Grützmann R; Wittel UA; Croner RS; Jacobasch L; Neumann UP; Reinacher-Schick A; Imhoff D; Boeck S; Keilholz L; Oettle H; Hohenberger WM; Golcher H; Bechstein WO; Uhl W; Pirkl A; Adler W; Semrau S; Rutzner S; Ghadimi M; Lubgan D
    Strahlenther Onkol; 2021 Jan; 197(1):8-18. PubMed ID: 32914237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Conversion Surgery for Unresectable Pancreatic Cancer After Long-Term Chemotherapy.
    Tsuchiya N; Matsuyama R; Murakami T; Yabushita Y; Sawada Y; Kumamoto T; Endo I
    World J Surg; 2020 Aug; 44(8):2752-2760. PubMed ID: 32291503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conversion surgery for initially unresectable pancreatic ductal adenocarcinoma with synchronous liver metastasis after treatment with FOLFIRINOX.
    Ozaki K; Hayashi H; Ikuta Y; Masuda T; Akaboshi S; Ogata K; Matumoto K; Ogawa K; Kamio T; Baba H; Takamori H
    Clin J Gastroenterol; 2019 Dec; 12(6):603-608. PubMed ID: 30993652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A R0 resection case of initially unresectable metastatic pancreatic cancer downstaged by FOLFIRINOX therapy.
    Sasaki T; Isayama H; Aoki T; Tanaka M; Hamada T; Nakai Y; Sakamoto Y; Hasegawa K; Morikawa T; Fukayama M; Kokudo N; Koike K
    Pancreas; 2014 Aug; 43(6):972-4. PubMed ID: 25010709
    [No Abstract]   [Full Text] [Related]  

  • 9. Adjuvant surgical therapy for patients with initially-unresectable pancreatic cancer with long-term favorable responses to chemotherapy.
    Kato K; Kondo S; Hirano S; Tanaka E; Shichinohe T; Tsuchikawa T; Matsumoto J
    J Hepatobiliary Pancreat Sci; 2011 Sep; 18(5):712-6. PubMed ID: 21455748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resection of Borderline Resectable and Locally Advanced Pancreatic Adenocarcinomas after Neoadjuvant Chemotherapy.
    Addeo P; Rosso E; Fuchshuber P; Oussoultzoglou E; De Blasi V; Simone G; Belletier C; Dufour P; Bachellier P
    Oncology; 2015; 89(1):37-46. PubMed ID: 25766660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of preoperative radiochemotherapy in patients with locally advanced pancreatic carcinoma.
    Lind PA; Isaksson B; Almström M; Johnsson A; Albiin N; Byström P; Permert J
    Acta Oncol; 2008; 47(3):413-20. PubMed ID: 17882555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pure laparoscopic DP-CAR procedure with portal vein resection].
    Voskanyan SE; Shabalin MV; Artemiyev AI; Kolyshev IY; Bogoevich Z; Kucherov NN; Bashkov AN; Naydenov EV
    Khirurgiia (Mosk); 2019; (9):93-98. PubMed ID: 31532174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of response in neoadjuvant therapy for exocrine pancreatic cancer.
    Vitello DJ; Bentrem DJ
    J Surg Oncol; 2021 May; 123(6):1449-1459. PubMed ID: 33831249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FOLFIRINOX-based neoadjuvant therapy in borderline resectable or unresectable pancreatic cancer: a meta-analytical review of published studies.
    Petrelli F; Coinu A; Borgonovo K; Cabiddu M; Ghilardi M; Lonati V; Aitini E; Barni S;
    Pancreas; 2015 May; 44(4):515-21. PubMed ID: 25872127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New developments in the treatment of pancreatic cancer].
    Marsman HA; Besselink MG
    Ned Tijdschr Geneeskd; 2016; 160():D538. PubMed ID: 27758723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
    Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T;
    Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advancements in the management of pancreatic cancer: 2013.
    Saif MW
    JOP; 2013 Mar; 14(2):112-8. PubMed ID: 23474549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localized Pancreatic Cancer: Multidisciplinary Management.
    Coveler AL; Herman JM; Simeone DM; Chiorean EG
    Am Soc Clin Oncol Educ Book; 2016; 35():e217-26. PubMed ID: 27249726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative chemotherapy, radiotherapy, and surgical resection of locally advanced pancreatic cancer.
    Wanebo HJ; Glicksman AS; Vezeridis MP; Clark J; Tibbetts L; Koness RJ; Levy A
    Arch Surg; 2000 Jan; 135(1):81-7; discussion 88. PubMed ID: 10636353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conversion surgery only for highly selected patients with unresectable pancreatic cancer: a satisfactory outcome in exchange for a lower resection rate.
    Natsume S; Shimizu Y; Senda Y; Hijioka S; Matsuo K; Ito S; Komori K; Abe T; Hara K
    Surg Today; 2019 Aug; 49(8):670-677. PubMed ID: 30730003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.